Zenrelia Education Session – Clinical Deep Dive

Dr Claude Stanislaus, Technical Veterinarian at Elanco Australia, will be presenting an education session on Zenrelia®, a newly available oral JAK inhibitor for the management of canine allergic and atopic dermatitis.

This session will focus on the scientific basis of the drug, including its mechanism of action, available clinical data, indications, and practical considerations for use in general practice. It will also address some of the recent discussion and commentary surrounding the medication, with the aim of providing context and supporting informed clinical decision-making.